Receptor radionuclide therapy with (90)Y-[DOTA](0)-Tyr(3)-octreotide ((90)Y-DOTATOC) in neuroendocrine tumours. - Bodei,L.; Cremonesi,M.; Grana,C. (Eur J Nucl Med Mol Imaging, 2004)